How much is CORXEL Pharmaceuticals worth in 2026?

CORXEL Pharmaceuticals has a current valuation of N/A based on their Later Stage VC (Series D1) round and secondary market data.

How much funding has CORXEL Pharmaceuticals raised?

CORXEL Pharmaceuticals has raised N/A in total funding across 1 funding rounds.

CORXEL Pharmaceuticals

Drug Discovery

CORXEL Pharmaceuticals valuation and funding history | Last updated: January 22, 2026 | 1 funding rounds

Current Valuation

N/A

As of January 22, 2026

Total Funding Raised

N/A

Across 1 round

Last Round

Later Stage VC (Series D1)

$287.0M

Last Funding

Jan 2026

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
January 22, 2026	Later Stage VC (Series D1)	$287.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

CORXEL Pharmaceuticals is currently valued at N/A as of January 22, 2026.

Track CORXEL Pharmaceuticals Valuation Updates

Get notified when CORXEL Pharmaceuticals raises new funding or valuation changes

Explore More Data

Detailed analysis for CORXEL Pharmaceuticals

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock CORXEL Pharmaceuticals's valuation history, funding rounds, and growth metrics.

No credit card required

What is CORXEL Pharmaceuticals Worth in 2026?

CORXEL Pharmaceuticals is a leading private company in the Drug Discovery sector. Track CORXEL Pharmaceuticals's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How CORXEL Pharmaceuticals Valuation is Determined

Private company valuations like CORXEL Pharmaceuticals's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.